The public health department in Pune, Maharashtra, India, has ordered a departmental inquiry and police investigation into the alleged theft of 20 vials of mephentermine sulphate at Aundh District Hospital (ADH). The inquiry was prompted by a two-member probe panel's findings, which revealed significant irregularities in drug handling and discrepancies in the hospital's records from 2023 to October 2025. Swapnil Chavan, a class 4 staff member, has been suspended under the Maharashtra Civil Services (Discipline and Appeal) Rules, 1979, and is currently attached to a rural hospital during the inquiry. The committee's report highlighted the risk of misuse of mephentermine, a Schedule H drug, which is typically administered by cardiologists and anesthesiologists, raising alarms about potential illegal distribution to bodybuilders and gym trainers. Dr. Bhagwan Pawar, deputy director of health services for the Pune region, emphasized the importance of identifying the individuals involved in the sale of these medicines and establishing accountability. A detailed report is expected from the civil surgeon soon.